RSS

contract research biotech (CRB)

Inoviem Scientific, a contract research biotech, has entered into a service-based partnership with XoNovo, a preclinical-stage biopharmaceutical company that is developing a proprietary small molecule for the treatment of neurodegenerative diseases more

News

Inoviem Scientific, a contract research biotech (CRB), has secured funding of €750k from existing financial partners to support the company’s growth. more

News